Search Results - "Barbus, S."

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistance by Depner, C., zum Buttel, H., Böğürcü, N., Cuesta, A. M., Aburto, M. R., Seidel, S., Finkelmeier, F., Foss, F., Hofmann, J., Kaulich, K., Barbus, S., Segarra, M., Reifenberger, G., Garvalov, B. K., Acker, T., Acker-Palmer, A.

    Published in Nature communications (29-07-2016)
    “…Diffuse invasion of the surrounding brain parenchyma is a major obstacle in the treatment of gliomas with various therapeutics, including anti-angiogenic…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival by Goidts, V, Bageritz, J, Puccio, L, Nakata, S, Zapatka, M, Barbus, S, Toedt, G, Campos, B, Korshunov, A, Momma, S, Van Schaftingen, E, Reifenberger, G, Herold-Mende, C, Lichter, P, Radlwimmer, B

    Published in Oncogene (05-07-2012)
    “…The concept of cancer stem-like cells (CSCs) has gained considerable attention in various solid tumors including glioblastoma, the most common primary brain…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Blue Cross and Blue Shield of Michigan Hospital Laboratory On-Site Review Project by DesHarnais, Susan, Kibe, Neel M., Barbus, Shirley

    Published in Inquiry (Chicago) (1983)
    “…Blue Cross and Blue Shield of Michigan assessed the intensity of inpatient laboratory use for similar patients in a sample of 30 short-term hospitals in three…”
    Get full text
    Journal Article